MACK — Merrimack Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Merrimack Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.6	14	14.2	19.4	18.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.7	16.5	14.7	19.8	19.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	—	—	—
Long Term Investments
Other Long Term Assets
Total Assets	20.1	16.8	14.7	19.8	19.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.77	0.77	0.562	0.589	0.441
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.77	0.77	0.562	0.589	0.441
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.3	16	14.2	19.2	18.7
Total Liabilities & Shareholders' Equity	20.1	16.8	14.7	19.8	19.2
Total Common Shares Outstanding